[(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate

C35H46N10O17P2S — CID 145362153

IUPAC[(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate
SMILESC=CCCC(=O)N(C)[C@@H](Cc1cscn1)C(=O)O[C@H]1[C@@H](O)[C@H](n2cnc3c(N)ncnc32)O[C@@H]1COP(=O)(O)O[C@H]1[C@@H](OC2CCCO2)[C@H](n2ccc(N)nc2=O)O[C@@H]1COP(=O)(O)O
InChIInChI=1S/C35H46N10O17P2S/c1-3-4-6-23(46)43(2)19(11-18-14-65-17-41-18)34(48)61-27-20(58-32(26(27)47)45-16-40-25-30(37)38-15-39-31(25)45)13-57-64(53,54)62-28-21(12-56-63(50,51)52)59-33(29(28)60-24-7-5-10-55-24)44-9-8-22(36)42-35(44)49/h3,8-9,14-17,19-21,24,26-29,32-33,47H,1,4-7,10-13H2,2H3,(H,53,54)(H2,36,42,49)(H2,37,38,39)(H2,50,51,52)/t19-,20+,21+,24?,26+,27+,28+,29+,32+,33+/m0/s1
InChIKeyDRNZHXUSAKPKKY-PJQHSAMMSA-N
MW972.82 g/mol
LogP-0.06
Rot. Bonds20

About [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate

[(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate (PubChem CID 145362153) has the molecular formula C35H46N10O17P2S and a molecular weight of 972.82 g/mol. Its IUPAC name is [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate.

Molecular Properties

Compound Name[(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate
PubChem CID145362153
Molecular FormulaC35H46N10O17P2S
Molecular Weight972.82 g/mol
Exact Mass972.22
IUPAC Name[(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate
SMILESC=CCCC(=O)N(C)[C@@H](Cc1cscn1)C(=O)O[C@H]1[C@@H](O)[C@H](n2cnc3c(N)ncnc32)O[C@@H]1COP(=O)(O)O[C@H]1[C@@H](OC2CCCO2)[C@H](n2ccc(N)nc2=O)O[C@@H]1COP(=O)(O)O
InChIInChI=1S/C35H46N10O17P2S/c1-3-4-6-23(46)43(2)19(11-18-14-65-17-41-18)34(48)61-27-20(58-32(26(27)47)45-16-40-25-30(37)38-15-39-31(25)45)13-57-64(53,54)62-28-21(12-56-63(50,51)52)59-33(29(28)60-24-7-5-10-55-24)44-9-8-22(36)42-35(44)49/h3,8-9,14-17,19-21,24,26-29,32-33,47H,1,4-7,10-13H2,2H3,(H,53,54)(H2,36,42,49)(H2,37,38,39)(H2,50,51,52)/t19-,20+,21+,24?,26+,27+,28+,29+,32+,33+/m0/s1
InChIKeyDRNZHXUSAKPKKY-PJQHSAMMSA-N
XLogP-0.06
TPSA369.70 Ų
H-Bond Donors6
H-Bond Acceptors24
Rotatable Bonds20
Heavy Atoms65
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500972.82
LogP ≤ 5-0.06
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate?
The IUPAC name of [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate (CID 145362153) is [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate.
What is the SMILES notation for [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate?
The canonical SMILES for [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate is C=CCCC(=O)N(C)[C@@H](Cc1cscn1)C(=O)O[C@H]1[C@@H](O)[C@H](n2cnc3c(N)ncnc32)O[C@@H]1COP(=O)(O)O[C@H]1[C@@H](OC2CCCO2)[C@H](n2ccc(N)nc2=O)O[C@@H]1COP(=O)(O)O.
What is the InChIKey of [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate?
The InChIKey is DRNZHXUSAKPKKY-PJQHSAMMSA-N. The full InChI is InChI=1S/C35H46N10O17P2S/c1-3-4-6-23(46)43(2)19(11-18-14-65-17-41-18)34(48)61-27-20(58-32(26(27)47)45-16-40-25-30(37)38-15-39-31(25)45)13-57-64(53,54)62-28-21(12-56-63(50,51)52)59-33(29(28)60-24-7-5-10-55-24)44-9-8-22(36)42-35(44)49/h3,8-9,14-17,19-21,24,26-29,32-33,47H,1,4-7,10-13H2,2H3,(H,53,54)(H2,36,42,49)(H2,37,38,39)(H2,50,51,52)/t19-,20+,21+,24?,26+,27+,28+,29+,32+,33+/m0/s1.
What are the key properties of [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate?
[(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate has a molecular weight of 972.82 g/mol, XLogP of -0.06, 20 rotatable bonds, 6 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3S,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-(oxolan-2-yloxy)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] (2S)-2-[methyl(pent-4-enoyl)amino]-3-(1,3-thiazol-4-yl)propanoate is sourced from PubChem (CID 145362153), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).